{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:00:50Z","timestamp":1791406850400,"version":"4.3.3"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.07.046","type":"journal-article","created":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T08:27:11Z","timestamp":1255768031000},"page":"D69-D72","source":"Crossref","is-referenced-by-count":116,"special_numbering":"S4","title":["Rift Valley fever vaccines"],"prefix":"10.1016","volume":"27","author":[{"given":"Tetsuro","family":"Ikegami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.07.046_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep cattle and man from east Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J Path Bacteriol"},{"key":"10.1016\/j.vaccine.2009.07.046_bib2","first-page":"403","article-title":"Rift Valley fever","volume":"vol. 1","author":"Peters","year":"1981"},{"issue":"7","key":"10.1016\/j.vaccine.2009.07.046_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"Bird","year":"2009","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2009.07.046_bib4","first-page":"431","article-title":"Rift Valley fever\u2014a review","volume":"5","author":"Weiss","year":"1957","journal-title":"Bull Epz Dis Afr"},{"key":"10.1016\/j.vaccine.2009.07.046_bib5","first-page":"65","article-title":"Rift Valley fever","volume":"10","author":"Easterday","year":"1965","journal-title":"Adv Vet Sci"},{"key":"10.1016\/j.vaccine.2009.07.046_bib6","series-title":"Fields virology","first-page":"1581","article-title":"Bunyaviridae: the viruses and their replication","author":"Schmaljohn","year":"2001"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.046_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.046_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","article-title":"Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease","volume":"362","author":"Bird","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.07.046_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1749-6632.1992.tb19652.x","article-title":"Rift Valley fever: present status and risk to the Western Hemisphere","volume":"653","author":"House","year":"1992","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.046_bib10","first-page":"197","article-title":"Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters","volume":"92","author":"Niklasson","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand [C]"},{"issue":"7","key":"10.1016\/j.vaccine.2009.07.046_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.046_bib12","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1128\/JVI.02095-06","article-title":"Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry","volume":"81","author":"Bird","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.07.046_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.89.5.660","article-title":"The development of a formalin-killed Rift Valley fever virus vaccine for use in man","volume":"89","author":"Randall","year":"1962","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.07.046_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.93.2.293","article-title":"Immunization against Rift Valley fever virus. Studies on the Immunogenicity of lyophilized formalin-Inactivated vaccine","volume":"93","author":"Randall","year":"1964","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.07.046_bib15","first-page":"124","article-title":"Rift Valley fever vaccine for humans","volume":"3","author":"Eddy","year":"1981","journal-title":"Contr Epidem Biostatist"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.046_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/inf.1982.14.issue-2.06","article-title":"Rift Valley fever virus vaccine trial: study of side-effects in humans","volume":"14","author":"Niklasson","year":"1982","journal-title":"Scand J Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.07.046_bib17","first-page":"181","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.046_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0264-410X(85)90060-X","article-title":"A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection","volume":"3","author":"Kark","year":"1985","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.07.046_bib19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/oxfordjournals.aje.a113471","article-title":"A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up","volume":"116","author":"Kark","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.07.046_bib20","series-title":"Infectious diseases of livestock with special reference to southern Africa","article-title":"Rift Valley fever","author":"Swanepoel","year":"2004"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.046_bib21","first-page":"261","article-title":"The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO\/FAO meeting","volume":"61","author":"World Health Organization","year":"1983","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.046_bib22","first-page":"45","article-title":"An inactivated rift valley fever vaccine","volume":"48","author":"Barnard","year":"1977","journal-title":"J S Afr Vet Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.046_bib23","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br J Exp Pathol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.07.046_bib24","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.046_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine","volume":"8","author":"Saluzzo","year":"1990","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.046_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-1702(97)00097-X","article-title":"Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation","volume":"52","author":"Vialat","year":"1997","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.046_bib27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0042-6822(89)90171-2","article-title":"Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus","volume":"169","author":"Takehara","year":"1989","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.046_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.virol.2008.05.033","article-title":"RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses","volume":"378","author":"Billecocq","year":"2008","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.046_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"Morrill","year":"1991","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.046_bib30","first-page":"166","article-title":"Serological evidence of arboviral infections among humans of coastal Kenya","volume":"94","author":"Morrill","year":"1991","journal-title":"J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.046_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0034-5288(92)90029-2","article-title":"Comparison of the pathogenicity for pregnant sheep of Rift Valley fever virus and a live attenuated vaccine","volume":"52","author":"Baskerville","year":"1992","journal-title":"Res Vet Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.046_bib32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4269\/ajtmh.1986.35.660","article-title":"Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus","volume":"5","author":"Moussa","year":"1986","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.046_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2460\/ajvr.1991.52.01.50","article-title":"Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever","volume":"52","author":"Hubbard","year":"1991","journal-title":"Am J Vet Res"},{"issue":"10","key":"10.1016\/j.vaccine.2009.07.046_bib34","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.046_bib35","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"Hunter","year":"2002","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2009.07.046_bib36","series-title":"Factors in the emergence of arbovirus diseases","first-page":"253","article-title":"Emergence of Rift Valley fever","author":"Peters","year":"1997"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.046_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.046_bib38","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/JVI.74.3.1538-1543.2000","article-title":"The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice","volume":"74","author":"Vialat","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.07.046_bib39","series-title":"FAO\/IAEA International Symposium on Applications of Gene-based Technologies for Improving Animal Production and Health in Developing Countries","article-title":"Pathogenicity and immunogenicity of the reassortant attenuated strain R566 of Rift Valley fever virus in sheep","author":"Thiongane","year":"2003"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.046_bib40","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"Bird","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.07.046_bib41","series-title":"Vaccines 89\u2019 modern approaches to new vaccines including prevention of AIDS","article-title":"Mapping protective determinants of Rift Valley fever virus using recombinant vaccinia virus","author":"Dalrymple","year":"1989"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.046_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/JVI.58.2.263-270.1986","article-title":"Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus","volume":"58","author":"Keegan","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.07.046_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01316748","article-title":"Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies","volume":"121","author":"Besselaar","year":"1991","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.046_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M-genome segment of Rift-Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"Schmaljohn","year":"1989","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.046_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.virol.2007.04.014","article-title":"Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins","volume":"366","author":"Gorchakov","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.07.046_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268808001696","article-title":"An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus","volume":"137","author":"Heise","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2009.07.046_bib47","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.046_bib48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.virol.2008.12.011","article-title":"Efficient production of Rift Valley fever virus-like particles: the antiviral protein MxA can inhibit primary transcription of bunyaviruses","volume":"385","author":"Habjan","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.07.046_bib49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-5-82","article-title":"Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins","volume":"5","author":"Liu","year":"2008","journal-title":"Virol J"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.046_bib50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.copbio.2007.10.013","article-title":"Virus-like particles-universal molecular toolboxes","volume":"18","author":"Ludwig","year":"2007","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.046_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley fever virus","volume":"385","author":"N\u00e4slund","year":"2009","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.vaccine.2009.07.046_bib52","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.07.046_bib53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley fever virus cDNA constructs","volume":"6","author":"Lagerqvist","year":"2009","journal-title":"Virol J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T20:26:07Z","timestamp":1739391967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09010548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":53,"alternative-id":["S0264410X09010548"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}